AnaptysBio, Inc.

Historical 13F Holders

Symbol
ANAB
CUSIP
032724106
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 161 40.0 M $743 M
2024 Q4 158 35.4 M $469 M
2024 Q3 178 33.7 M $1.13 B
2024 Q2 144 29.9 M $749 M
2024 Q1 145 30.5 M $687 M
2023 Q4 130 30.9 M $663 M
2023 Q3 124 30.4 M $546 M
2023 Q2 126 30.2 M $615 M
2023 Q1 120 31.0 M $675 M
2022 Q4 126 34.0 M $1.05 B
2022 Q3 118 32.6 M $831 M
2022 Q2 128 31.2 M $633 M
2022 Q1 134 29.7 M $736 M
2021 Q4 145 27.8 M $966 M
2021 Q3 131 27.6 M $749 M
2021 Q2 132 27.8 M $722 M
2021 Q1 138 29.2 M $629 M
2020 Q4 144 28.6 M $615 M
2020 Q3 141 29.1 M $430 M
2020 Q2 131 30.1 M $673 M
2020 Q1 129 31.3 M $442 M
2019 Q4 144 28.6 M $465 M
2019 Q3 133 29.1 M $1.02 B
2019 Q2 142 30.3 M $1.71 B
2019 Q1 141 29.1 M $2.13 B
2018 Q4 132 29.2 M $1.86 B
2018 Q3 156 29.1 M $2.90 B
2018 Q2 134 25.0 M $1.78 B
2018 Q1 146 24.5 M $2.55 B
2017 Q4 123 23.8 M $2.39 B
2017 Q3 72 17.8 M $621 M
2017 Q2 52 13.7 M $328 M
2017 Q1 52 13.8 M $382 M